Business

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

Immuron LimitedSeptember 5, 20243

Immuron Plans Phase 2 Trial for IMM-529 following FDA review

About this update from Immuron Limited

Immuron Ltd has released a press release. View Attachment

View stock analysis, news, and events for Immuron Limited

More from Immuron Limited

Immuron to launch PROIBS® in the United States

September 4, 2026

PROIBS US Distribution Agreement

September 3, 2026

All Immuron Limited news →